Lyme disease: point/counterpoint (Q36140640)

12 August 2017

1 reference

title

Lyme disease: point/counterpoint (English)

1 reference

12 August 2017

0 references

1

Raphael B Stricker

1 reference

12 August 2017

Andrew Lautin

2

1 reference

12 August 2017

Joseph J Burrascano

series ordinal

3

1 reference

12 August 2017

publication date

1 April 2005

1 reference

Expert Review of Anti-infective Therapy

12 August 2017

published in

1 reference

12 August 2017

volume

3

1 reference

12 August 2017

issue

2

1 reference

12 August 2017

page(s)

155-165

1 reference

The Overdiagnosis of Lyme Disease

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Syphilis in renaissance Europe: rapid evolution of an introduced sexually transmitted disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Performance of 45 laboratories participating in a proficiency testing program for Lyme disease serology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Role of Serology in the Diagnosis of Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Detection of Borrelia burgdorferi DNA in muscle of patients with chronic myalgia related to Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Borrelia burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Disease-specific diagnosis of coinfecting tickborne zoonoses: babesiosis, human granulocytic ehrlichiosis, and Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Concurrent infection of the central nervous system by Borrelia burgdorferi and Bartonella henselae: evidence for a novel tick-borne disease complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Detection of Borrelia burgdorferi, Ehrlichia chaffeensis, and Anaplasma phagocytophilum in ticks (Acari: Ixodidae) from a coastal region of California

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

‘Lyme disease’: ancient engine of an unrecognized borreliosis pandemic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Current and novel therapies for Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Evidence-based guidelines for the management of Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Treatment of Lyme disease: a medicolegal assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Modulation of host immunity by haematophagous arthropods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

The basis of persistent bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

An immune evasion mechanism for spirochetal persistence in Lyme borreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Lyme borreliosis in Sweden--diagnostic performance of five commercial Borrelia serology kits using sera from well-defined patient groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Patterns of Lyme disease diagnosis and treatment by family physicians in a southeastern state

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Human behaviors elevating exposure to Ixodes pacificus (Acari: Ixodidae) nymphs and their associated bacterial zoonotic agents in a hardwood forest

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Quantitative detection of Borrelia burgdorferi in 2-millimeter skin samples of erythema migrans lesions: correlation of results with clinical and laboratory findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Formation and cultivation of Borrelia burgdorferi spheroplast-L-form variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to metronidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Why Is Chronic Lyme Borreliosis Chronic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Borrelia burgdorferi and Treponema pallidum: a comparison of functional genomics, environmental adaptations, and pathogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Complement Resistance of Borrelia burgdorferi Correlates with the Expression of BbCRASP-1, a Novel Linear Plasmid-encoded Surface Protein That Interacts with Human Factor H and FHL-1 and Is Unrelated to Erp Proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

bdrF2 of Lyme disease spirochetes is coexpressed with a series of cytoplasmic proteins and is produced specifically during early infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Protective niche for Borrelia burgdorferi to evade humoral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Genetic exchange and plasmid transfers in Borrelia burgdorferi sensu stricto revealed by three-way genome comparisons and multilocus sequence typing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Genome-wide transposon mutagenesis of Borrelia burgdorferi for identification of phenotypic mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Experimental assessment of the roles of linear plasmids lp25 and lp28-1 of Borrelia burgdorferi throughout the infectious cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Extracellular secretion of the Borrelia burgdorferi Oms28 porin and Bgp, a glycosaminoglycan binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Borrelia burgdorferi, host-derived proteases, and the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Erythromycin resistance in Borrelia burgdorferi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Intracellular persistence of Borrelia burgdorferi in human synovial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Coiling phagocytosis of Borrelia burgdorferi by primary human macrophages is controlled by CDC42Hs and Rac1 and involves recruitment of Wiskott-Aldrich syndrome protein and Arp2/3 complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Survival strategies of Borrelia burgdorferi, the etiologic agent of Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

The immunological aspects of latency in tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

A family of autocrine growth factors in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Quorum sensing by the Lyme disease spirochete

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis suppresses IL-2 and IFN gamma production and promotes an IL-4 response in C3H/HeJ mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Clinical impact of persistent Bartonella bacteremia in humans and animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Treatment of patients with persistent symptoms and a history of Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Detection of Borrelia burgdorferi DNA by Polymerase Chain Reaction in Synovial Fluid from Patients with Lyme Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Seronegative chronic relapsing neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Progress and controversy surrounding vaccines against Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

An ecological approach to preventing human infection: vaccinating wild mouse reservoirs intervenes in the Lyme disease cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Decreased CD57 lymphocyte subset in patients with chronic Lyme disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Comparison of in vitro activities of ketolides, macrolides, and an azalide against the spirochete Borrelia burgdorferi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Functional Brain Imaging and Neuropsychological Testing in Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Management of tuberculosis in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Correlation between serum doxycycline concentrations and serologic evolution in patients with Coxiella burnetii endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

Ixodes ricinus tick salivary gland extract inhibits IL-10 secretion and CD69 expression by mitogen-stimulated murine splenocytes and induces hyporesponsiveness in B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.2.155

21 January 2018

Identifiers

DOI

10.1586/14787210.3.2.155

1 reference

12 August 2017

1 reference